Our exosome product, RExO, is comprised of tiny extracellular vesicles derived from mesenchymal stem cells. They are 40-100 nanometers in size and contain lipids, messenger-RNA, micro-RNA, signaling cytokines, and proteins to help create a regenerative response to various treatment therapies. Exosomes have a variety of reported functions and some of their better-documented activities are associated with a form of immune regulation. Exosomes are anti-inflammatory, anti-fibrotic, cross the “blood-brain barrier,” have minimal risk of clumping, are easy to administer, contain nearly three times more growth factors compared to adult stem cells, and influence the growth of target cells.
Exosomes are primarily used in cell signaling and are found in all bodily fluids. Cells communicate with each other using cytokines. These are proteins that are excreted by one cell and tell another cell what to do. Think of an orchestra and how the conductor ensures all instruments produce beautiful music instead of noise. The conductor, in this case, is the exosome. The use of exosomes also holds the promise of being more cost-effective from the point of view of storage, logistics, manufacturing, and delivery.
Potential Treatment Ares
RExO™ is processed from healthy, carefully screened mothers at the time of scheduled cesarean section. All donors are pre-screened and undergo comprehensive serological testing that includes:
*Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR Part 493.